The administration of the trump signed a contract for the production of generics to fight COVID-19

The administration of U.S. President Donald trump has signed with pharmaceutical company Phlow Corp contract manufacturing of generics and active pharmaceutical ingredients necessary for the country to treat patients with coronavirus infection. About it reports Reuters.

The transaction value amounted to 354 million dollars. In US government circles, this contract was called a historic event to return the production of drugs into the country.

Phlow Corp is a generic company based in Virginia, which currently manufactures drugs in factories in India and China, according to the NYT.

Leave a Reply

Your email address will not be published. Required fields are marked *


For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]